Luye Pharma AG
🇩🇪Germany
- Country
- 🇩🇪Germany
- Ownership
- Subsidiary
- Established
- 1997-01-01
- Employees
- 101
- Market Cap
- -
- Website
- https://www.luyepharma.eu
Clinical Trials
0
Active:0
Completed:0
Trial Phases
0 Phases
Drug Approvals
14
NMPA:6
CIMA_AEMPS:6
SFDA:2
Drug Approvals
Rivastigmine Transdermal Patch
- Product Name
- 利斯的明透皮贴剂
- Approval Number
- 国药准字HJ20200018
- Approval Date
- Mar 25, 2025
NMPA
Rivastigmine Transdermal Patch
- Product Name
- 利斯的明透皮贴剂
- Approval Number
- 国药准字HJ20200019
- Approval Date
- Mar 25, 2025
NMPA
Rivastigmine Twice Weekly Transdermal Patch
- Product Name
- 利斯的明透皮贴剂
- Approval Number
- 国药准字HJ20230123
- Approval Date
- Oct 27, 2023
NMPA
Rivastigmine Twice Weekly Transdermal Patch
- Product Name
- 利斯的明透皮贴剂
- Approval Number
- 国药准字HJ20230124
- Approval Date
- Oct 27, 2023
NMPA
Rivastigmine Transdermal Patch
- Product Name
- 利斯的明透皮贴剂
- Approval Number
- H20200019
- Approval Date
- Jun 2, 2020
NMPA
Rivastigmine Transdermal Patch
- Product Name
- 利斯的明透皮贴剂
- Approval Number
- H20200018
- Approval Date
- Jun 2, 2020
NMPA
Clinical Trials
No trials found
News
No news found